BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML). (Q48396875)
Jump to navigation
Jump to search
scientific article published on 27 November 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML). |
scientific article published on 27 November 2009 |
Statements
BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML) (English)
Joaquín Díaz-Mediavilla
Noemí Puig
Ana Balanzategui
Alfonso García de Coca
Carlos Santamaría
Cristina Pérez
María D Caballero
María V Mateos
Fernando Ramos
José M Alonso
Pilar Giraldo
José A Queizán
Juan N Rodríguez
27 November 2009